Gateway Investment Advisers’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Sell
2,241
-884
-28% -$183K ﹤0.01% 621
2026
Q1
$702K Buy
3,125
+673
+27% +$168K 0.01% 405
2025
Q4
$591K Buy
2,452
+1,177
+92% +$301K 0.01% 431
2025
Q3
$349K Buy
+1,275
New +$348K ﹤0.01% 452
2025
Q2
Sell
-3,486
Closed -$780K 507
2025
Q1
$780K Sell
3,486
-1,154
-25% -$269K 0.01% 355
2024
Q4
$1.06M Sell
4,640
-782
-14% -$188K 0.01% 320
2024
Q3
$1.32M Buy
5,422
+2,034
+60% +$455K 0.01% 292
2024
Q2
$649K Sell
3,388
-792
-19% -$161K 0.01% 365
2024
Q1
$828K Sell
4,180
-34
-0.8% -$6.23K 0.01% 346
2023
Q4
$725K Buy
4,214
+11
+0.3% +$1.69K 0.01% 358
2023
Q3
$621K Buy
4,203
+940
+29% +$170K 0.01% 365
2023
Q2
$713K Sell
3,263
-7
-0.2% -$1.56K 0.01% 349
2023
Q1
$716K Buy
3,270
+639
+24% +$139K 0.01% 356
2022
Q4
$548K Buy
2,631
+240
+10% +$52.7K 0.01% 401
2022
Q3
$522K Buy
2,391
+214
+10% +$48.7K 0.01% 403
2022
Q2
$456K Buy
2,177
+19
+0.9% +$4.04K 0.01% 431
2022
Q1
$523K Buy
2,158
+143
+7% +$34.6K 0.01% 427
2021
Q4
$525K Sell
2,015
-75
-4% -$19.5K 0.01% 417
2021
Q3
$551K Sell
2,090
-28
-1% -$7.66K 0.01% 406
2021
Q2
$522K Sell
2,118
-32
-1% -$6.73K 0.01% 423
2021
Q1
$417K Sell
2,150
-60
-3% -$12K ﹤0.01% 440
2020
Q4
$470K Sell
2,210
-132
-6% -$26.3K 0.01% 418
2020
Q3
$401K Sell
2,342
-97,353
-98% -$18M ﹤0.01% 423
2020
Q2
$19.1M Sell
99,695
-304
-0.3% -$49.7K 0.23% 100
2020
Q1
$14.7M Sell
99,999
-8,801
-8% -$1.4M 0.18% 115
2019
Q4
$16.9M Sell
108,800
-2,649
-2% -$382K 0.17% 132
2019
Q3
$15.1M Sell
111,449
-3,987
-3% -$522K 0.15% 147
2019
Q2
$14.1M Sell
115,436
-264
-0.2% -$29.2K 0.13% 161
2019
Q1
$12M Sell
115,700
-7,426
-6% -$766K 0.11% 177
2018
Q4
$14M Sell
123,126
-190
-0.2% -$20.4K 0.13% 158
2018
Q3
$14.2M Buy
123,316
+6,739
+6% +$738K 0.12% 171
2018
Q2
$12.1M Sell
116,577
-635
-0.5% -$64.3K 0.11% 181
2018
Q1
$11.5M Sell
117,212
-1,462
-1% -$138K 0.1% 186
2017
Q4
$10.1M Sell
118,674
-37,330
-24% -$3.08M 0.09% 195
2017
Q3
$12M Buy
156,004
+54,058
+53% +$4.14M 0.1% 182
2017
Q2
$7.94M Buy
101,946
+16,565
+19% +$1.19M 0.07% 215
2017
Q1
$6.14M Buy
85,381
+26,015
+44% +$1.8M 0.06% 242
2016
Q4
$3.68M Sell
59,366
-18,492
-24% -$1.13M 0.03% 299
2016
Q3
$5.04M Buy
77,858
+2,000
+3% +$133K 0.04% 263
2016
Q2
$4.8M Buy
75,858
+122
+0.2% +$7.19K 0.04% 273
2016
Q1
$4.38M Sell
75,736
-27,708
-27% -$1.57M 0.04% 270
2015
Q4
$5.55M Buy
103,444
+14,661
+17% +$826K 0.05% 260
2015
Q3
$4.52M Buy
88,783
+572
+0.6% +$30.8K 0.04% 284
2015
Q2
$4.97M Buy
+88,211
New +$5.57M 0.04% 278

Other funds holding RMD

Gateway Investment Advisers's RMD Position: Q2 2026 in Review

Gateway Investment Advisers reduced its ResMed (RMD) stake by 28% in Q2 2026, selling an estimated $183K and leaving 2,241 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #621.

Gateway Investment Advisers first reported a position in RMD in Q2 2015 and has held it in 44 quarters since. The position peaked at $19.1M in Q2 2020. 182 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Gateway Investment Advisers held 2,241 shares of ResMed worth $437K as of Q2 2026.
  • Gateway Investment Advisers sold 884 ResMed shares in Q2 2026, an estimated $183K.
  • ResMed made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #621 holding.
  • Gateway Investment Advisers first reported a position in ResMed in Q2 2015 and has held it in 44 quarters since.
  • Gateway Investment Advisers's ResMed position peaked at $19.1M in Q2 2020.
  • 182 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.